|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | CA 242 ELISA Assay | C-Peptide ELISA Assay | Gd-IgA1 (Galactose-deficient IgA1) ELISA | Human TPMT (Thiopurine S-methyltransferase) ELISA | Vasoactive Intestinal Polypeptide (VIP) RIA |
| Catalog Number | 101-85 | IB79101 | 27600 | IB08001 | RB311RUO |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Solid phase sandwich ELISA for the determination of CA 242 cancer antigen in serum. For research use only, not for use in diagnostic procedures. Please note this assay has a 5 kit purchase minimum. | Solid phase enzyme immunoassay (ELISA) for the determination of C-Peptide in serum, plasma and urine. For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination of Gd-IgA1 (Galactose-deficient IgA1) in human serum, EDTA-plasma, and urine. For research use only, not for use in diagnostic procedures.
Galactose-deficient IgA1 (Gd-IgA1) has attracted a lot of attention as a critical effector molecule in the Solid phase sandwich ELISA for the determination of Gd-IgA1 (Galactose-deficient IgA1) in human serum, EDTA-plasma, and urine. For research use only, not for use in diagnostic procedures.
Galactose-deficient IgA1 (Gd-IgA1) has attracted a lot of attention as a critical effector molecule in the pathogenesis and progression of IgA nephropathy (IgAN) in recent studies. It has been suggested that several O-link glycans-modified regions exist in the heavy chain hinge region of human IgA1 molecule and Gd-IgA1 circulates in the bloodstream of test samples with the pathological condition of IgAN.... Read More | The Human TPMT (Thiopurine S-methyltransferase) ELISA has been designed for the detection of TPMT in serum, plasma, tissue homogenates and other biological fluids. For research use only, not for use in diagnostic procedures. | Radioimmunoassay (RIA) for the determination of Vasoactive Intestinal Polypeptide (VIP) in human plasma. For research use only, not for use in diagnostic procedures. |
| Detection Target | Complement Factor P (Properdin) | Dopamine | Metanephrine / Normetanephrine | Pancreatic Polypeptide | Vasoactive Intestinal Polypeptide (VIP) |
| Sample Type | Human serum or EDTA plasma. | Tissue Homogenates, Dialysates, Urine | Urine | Serum | Blood Plasma |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Radio Immuno Assay (RIA) |
| Detection Range | 15 to 150 U/mL | 0.2 to 16.0 ng/mL | 1.56 to 100.0 ng/mL | 0 / 3.125 - 200ng/ml | 3.8 to 120 pmol/L |
| Sensitivity | Inquire | 0.25 ng/mL x C (must be multipled by a correction factor dependent on sample volume). | Metanephrine: 13 ng/mL; Normetanephrine: 23 ng/mL. | 3 pmol/L | 3 pmol/L |
| Assay Time | 3 hrs 30 mins (incubation) | 1 hr 50 mins (incubation) | 2 hours (incubation) | 3 hour, 30 min. total incubation time. | 48 hrs 45 mins (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |